http://networkedblogs.com/MUaDs

First US Cases of Borrelia Miyamotoi Identified

 

Updating Lyme Disease Tests

These results suggest that inclusion of B. miyamotoi in the two-tier testing for Lyme disease is warranted, just as it is now included in testing panels in Russia, and in parts of Europe. Unlike the Russian cases, however, none of the patients in this study had compromised immune systems, also highlighting a need to consider the diagnosis of B. miyamotoi infection where symptoms of Lyme disease are present in otherwise healthy individuals.